INTRODUCTION
Whether or not anti-epileptic drugs alter the natural history of epilepsy has become an issue of considerable importance and recent controversy 1 ,2. If the immediate treatment of new cases of epilepsy with anti-epileptic drugs (AED) prevents the development of intractable epilepsv-, then the common policy of not treating first seizures would have to be reconsidered. We discuss the evidence for such a claim.
The interpretation of the results of many of the relevant epidemiological and clinical studies is confounded by two problems. First, as epilepsy is defined by the occurrence of seizures, it is not possible to tell in patients receiving AEDs who have ceased having seizures whether the condition is 'controlled' or 'cured'. Second, in patients whose epilepsy becomes intractable, it is often not possible to distinguish whether this is because of an intrinsic severity from the onset or whether the early seizures have played a part in the development of the intractable state.
THE NATURAL HISTORY OF SEIZURES
Gowers in 1881 observed that a long history of epilepsy prior to hospital consultation worsened the final outcome" and he promoted the concept that 'each attack facilitated the occurrence of another'. Rodin's 1968 survey of the longterm remission rate in epilepsy concluded that only 30% of patients ever achieved a 2 year remissions. Both studies, however, are confounded by selection bias towards more severe cases. Recent community based studies have now shown that 70% of patients achieve a period of remission lasting at least 5 vears", Clearly, therefore, most epilepsy does not become intractable.
Studies of the natural history of newly diagnosed epilepsy have led Reynolds et al. to revive Gowers's proposal and to argue that the early course of epilepsy determines the ultimate chance of remission.'. In a cohort of 106 newly diagnosed patients they observed that, in those who continued to have seizures in the first 2 years of treatment, the remission rate was halved", However, these data do not provide evidence that seizures after the start of treatment caused intractability: their occurrence could simply have predicted it. Examining retrospectively the pattern of seizures in 183 patients presenting with tonic-clonic seizures, Eiwes et aI. found that the interval between successive seizures diminished". In 82 patients who had had at least three untreated seizures, the median interval between second and third seizure was 18 weeks shorter than the median interval between the first and second seizure. The inference drawn was that this early 'acceleration' of seizures predicted later intractability. However, there is no evidence that this inference is valid.
What predicts the eventual remission of epilepsy? The key factor seems to be aetiology. Several childhood syndromes, such as benign neonatal convulsions, childhood absence epilepsy, and benign epilepsy of childhood with rolandic spikes have an excellent prognosis. The latter remits by the late teens independent of the duration or frequency of seizures, and is sometimes not treated with AEDs 9 . Annegers et aI. have reported on the 20-year follow up of patients with epilepsy, and analysed this by aetiology, seizure type, age and medication status". Patients with idiopathic or cryptogenic epilepsy had a probability of being in remission (5 consecutive years of seizure freedom) of 74%, compared with 46% in those with neurological deficits since birth. They observed, however, that the remission rate for those with symptomatic epilepsy acquired later in life was equivalent to that in idiopathic or cryptogenic epilepsy. The lack of difference between these two aetiological groups may be accounted for by misclassification of symptomatic cases as cryptogenic, because of the lack of sophisticated neuroimaging at the time of the study. These studies need to be repeated with the benefit of modern diagnostic methods, including magnetic resonance imaging, to define the prognosis of individual epilepsy syndromes.
The natural history of febrile seizures provides further evidence that seizures in themselves do not necessarily provoke intractable epilepsy. Febrile seizures occur in 2%-5% of children before the age of 5, yet 97.5% of them will not go on to develop epilepsy 10. In the latter study, the risk of developing epilepsy was greater in children with pre-existing developmental abnormalities, a genetic predisposition, and those in whom the febrile seizure was complex (prolonged, focal or repeated). In another study of febrile seizures, a multivariate analysis of risk factors revealed that subsequent partial seizures were associated with prolonged, focal or repeated febrile seizures, but subsequent generalized seizures were associated with a family history of epilepsy and repeated febrile seizures 11. There is both animal and human evidence that prolonged seizures cause mesial temporal lobe damage and that this is associated with later temporal lobe epilepsy 12, 13. The fact that different types of epilepsy develop in adult life after febrile seizures in childhood, depending on the 'risk factors' involved, suggests that there is a diversity of causal pathways. In addition, despite the fact that prophylactic anti-epileptic treatment can reduce the chance of further febrile seizures, there is no evidence that it reduces the later development of epilepsy.
An important area of inquiry is the natural history of untreated epilepsy. First, there is circumstantial evidence that 50% of people with completely untreated epilepsy eventually go into remission'". Secondly, if untreated seizures caused intractability, one would expect to find a higher prevalence of chronic epilepsy in communities with a high incidence of epilepsy but without access to therapy. Recent population based studies in Ecuador, Nigeria and Ethiopia have found prevalence rates of active epilepsy no different from those in the developed countries, despite the fact that less than 5% of the patients with epilepsy in the studies from Nigeria and Ethiopia had been exposed to any treatment with AEDs15-17.
TRIALS OF ANTI-EPILEPTIC DRUG TREATMENT
The ideal context for establishing whether anti-epileptic drugs can prevent the development of an intractable state would be to prevent seizures occurring in patients at high risk of developing them: for example after head injury or a 'first seizure'. The prophylactic AED treatment of head injury has proved ineffective 18• Two randomized trials of immediate versus delayed treatment after a first seizure have reported that the chance of a second seizure is reduced by AED therapy19,20. In the First Seizure Trial Group study, the cumulative risk of a second seizure at 24 months was 25% treated and 51% untreated-", This is evidence that immediate treatment can suppress seizures, but does not yet establish that it alters the eventual outcome. Another trial, sponsored by the Medical Research Council, is currently underway (more information available from Professor D Chadwick, Department of Neurosciences, Walton Hospital, Liverpool L9 1AE, England).
A recent examination of the efficacy of treatment in patients who had had untreated seizures for many years in rural Kenya has shed important light on this topic/", Three hundred and two patients with active epilepsy were recruited into a trial that compared carbamazepine and phenobarbitone. Two hundred and forty-nine completed the study, of whom 53% were seizure free in the second 6 months of the study and a further 26% had more than a 50% reduction in seizures. Eighty-one per cent of patients had never received an AED before, 52% had had epilepsy for more than 5 years and 38% had experienced more than 100 seizures. Neither the duration of treatment nor the number of seizures was predictive of outcome. Similar results have been reported from Ecuador and Malawi 22,23. The efficacy of AED treatment in these studies was very similar to that reported by investigators in newly diagnosed patients in the developed world/", which suggests that the failure to treat early epilepsy does not inevitably lead to intractable epilepsy.
THE NEUROBIOLOGY OF EPILEPSY
The idea that repeated seizures can lead to intractable epilepsy has been influenced by three biological models: kindling; lesion models of temporal lobe epilepsy; and secondary epileptogenesis. The phenomenon of kindling, described by Goddard in 1967, is the development of an epileptic condition as a result of repeated low-intensity subconvulsive electrical stimulationv'. Rats stimulated in the amygdala initially develop electrographic seizures ('afterdischarges') without accompanying motor or behavioural changes. If brief daily stimulation is repeated, seizures develop, with a progression from mouth movements only, eventually to clonic motor activity, rearing and loss of postural control when kindling is complete 26 . This change in response to stimulation is then permanent, so that months later one stimulus will produce the full response. Further stimulation can give rise to a condition in which spontaneous seizures occur. Kindling can also follow chemical stimulation 27 and repeated sound stimuli in rats genetically susceptible to audiogenic seizures-". All animals can be kindled, though the ease with which this can be done varies considerably; in primates it is difficult. Other animal models of epilepsy depend on prolonged seizures (induced electrically or chemically) producing an intractable epileptic state/", Hippocampal structures in animals subjected to such lesions undergo a variety of neuroanatomical changes, including cell loss in hippocampal area CA3, and mossy fibre sprouting30. Kindled animals have shown neuronal loss in the hilar region of the dentate gyrus (part of the hippocampus) in addition to mossy fibre sprouting 31. Evidence of mossy fibre sprouting as well as neuronal loss has been found in humans with long-standing temporal lobe epilepsy32. As yet, there is insufficient evidence to establish that these structural changes are responsible for the neuronal hyperexcitability found in temporal lobe epilepsy. However, Sutula has speculated that both prolonged and repeated brief seizures cause neuronal loss and other structural changes that then result in an intractable epileptic state B .
Multiple foci of epileptic activity are not uncommonly found in patients with severe intractable partial epilepsies. Do these foci represent multiple areas of underlying pathology or are they a consequence of prolonged epilepsy causing secondary epileptogenesis? Secondary epileptogenesis is the induction, by an actively discharging epileptic focus, of a similar independently discharging focus elsewhere in the brain. Experiments in rats have shown that, after the creation of a unilateral cold induced epileptic focus, secondary contralateral foci may develop, and that these eventually become independent of the primary focus and can cause clinical seizures". This has not been reliably replicated in primates 35 ,36. Evidence that this occurs regularly in humans has also been elusive. However, Morrell has now documented evidence of the development of secondary epileptic foci in a small number of patients with apparently unilateral structural brain lesions whom he followed up carefully over several years 37 . Removal of the primary lesion sometimes led to the abolition of the secondary focus, but in others it remained clinically active. Secondary epileptogenesis would on present evidence, however, appear to be a rare event.
CONCLUSION
It is now known that the great majority of epilepsies go into remission, in some syndromes independent of any treatment. The results of AED trials in drug naive patients with active epilepsy in the developing world suggest that the prognosis, on a population basis, is not substantially affected by failure to treat early on. The current trials of early versus delayed treatment have yet to demonstrate that the eventual outcome, once treatment is withdrawn, is affected by the duration before the initiation of treatment. There remains, however, a puzzle that requires further research. Most types of epilepsy do remit, yet some forms clearly are intractable, and evidence from the natural history of temporal lobe syndromes and from animal models would suggest that ongoing seizures can have a permanently detrimental effect. Why do seizures in these types of epilepsy appear to be particularly harmful? We need to understand more about the mechanism that renders these epilepsies 'progressive'. Once it is recognized that seizures are simply a symptom, it becomes clear that the natural history of the epilepsy must ultimately be determined by the underlying aetiology and neurobiol ogy 38. 
